share_log

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Director GLOCER THOMAS H

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Director GLOCER THOMAS H

默沙東 | 4:持股變動聲明-董事 GLOCER THOMAS H
SEC announcement ·  03/29 16:18
Moomoo AI 已提取核心訊息
On March 28, 2024, Thomas H. Glocer, associated with Merck & Co., Inc. [MRK], reported a transaction involving the company's common stock. The action, which was of a direct nature, resulted in Glocer holding a total of 5,100 shares of Merck & Co. following the transaction. The details of the transaction, including the number of shares acquired or disposed of and the price per share, were not disclosed in the announcement.
On March 28, 2024, Thomas H. Glocer, associated with Merck & Co., Inc. [MRK], reported a transaction involving the company's common stock. The action, which was of a direct nature, resulted in Glocer holding a total of 5,100 shares of Merck & Co. following the transaction. The details of the transaction, including the number of shares acquired or disposed of and the price per share, were not disclosed in the announcement.
2024 年 3 月 28 日,與默沙東公司 [MRK] 關聯的 Thomas H. Glocer 報告了一筆涉及公司普通股的交易。該行動具有直接性質,導致Glocer在交易後共持有默沙東公司5,100股股份。該交易的細節,包括收購或處置的股票數量和每股價格,未在公告中披露。
2024 年 3 月 28 日,與默沙東公司 [MRK] 關聯的 Thomas H. Glocer 報告了一筆涉及公司普通股的交易。該行動具有直接性質,導致Glocer在交易後共持有默沙東公司5,100股股份。該交易的細節,包括收購或處置的股票數量和每股價格,未在公告中披露。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息